Sorafenib in Treating Patients With Kidney Cancer That Has Spread to the Brain

NCT00301847 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

NIH

Sponsor class

Conditions

Kidney Cancer
Metastatic Cancer

Interventions

DRUG: sorafenib tosylate

Sponsor

National Cancer Institute (NCI)